On the past 21st of December 2023, Miłosz Parczewski, EuCARE partner from the Pomeranian Medical University in Poland, was appointed National Consultant for Infectious Diseases by Polish Minister of Health. This achievement is an important recognition of Milosz important clinical and research work on Infectious Diseases and specially in Virology.
Miłosz Parczewski received the MD diploma at the Pomeranian Medical University, Szczecin, Poland in 2002 and a Ph.D diploma in molecular epidemiology of HIV in 2007. He became a Professor of Medicine in 2016.
He is currently Vice-president (from 2023) and member of the Governing Board of the European AIDS Clinical Society (EACS) (from 2020). Previously he was EACS fellow in the Exchange Programme for young HIV physicians (2006), under the supervision of Dr Clifford Leen, Western General Hospital, Edinburgh, UK.
From the beginning of the medical career remains an active practitioner in infectious diseases (ID specialist diploma obtained in 2011), currently leading the Department of Infectious, Tropical Diseases and Acquired Immunodeficiency of the Pomeranian Medical University, Szczecin, Poland with the additional position of the Regional Consultant for Infectious Diseases and COVID-19.
His research focuses on the molecular epidemiology of HIV infection and HCV coinfection: aspects of the genetic variability of the host with the key interest in chemokine and interleukin receptor genes, HIV genetic variability – evolution of drug resistance, including integrase mutations and tropism, HCV resistance as well as phylogeographic tracing of the viral transmission and recombination, involved in the local implementation of next generation sequencing technologies for HIV and HCV.
Furthermore, key interests focus on the association between genetic HIV-1 infection susceptibility and survival and variants of the host associated with the drug adverse reactions, as well as implementation of pre-exposure prophylaxis and, more recently, migrant care. Since 2017 he was appointed a president of the Polish Scientific AIDS Society, Council Member for the European Society on Antiviral Resistance, and recently associate editor of BMJ STI and HIV Medicine journals. He is author of multiple original scientific publications in the field of HIV/AIDS, active participant of the international conferences in the field, investigator in the clinical trials and cohorts including EUROSIDA, previously involved in the international projects such as “Rapid Assessment of Drug Law & Policy in the Former Soviet Union & Central Eastern Europe” funded by National Institute of Health.
